Literature DB >> 11267995

The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?

F Tirone1.   

Abstract

PC3(TIS21/BTG2) is the founding member of a family of genes endowed with antiproliferative properties, namely BTG1, ANA/BTG3, PC3B, TOB, and TOB2. PC3 was originally isolated as a gene induced by nerve growth factor during neuronal differentiation of rat PC12 cells, or by TPA in NIH3T3 cells (named TIS21), and is a marker for neuronal birth in vivo. This and other findings suggested its implication in the process of neurogenesis as mediator of the growth arrest before differentiation. Remarkably, its human homolog, named BTG2, was shown to be p53-inducible, in conditions of genotoxic damage. PC3(TIS21/BTG2) impairs G(1)-S progression, either by a Rb-dependent pathway through inhibition of cyclin D1 transcription, or in a Rb-independent fashion by cyclin E downregulation. PC3(TIS21/BTG2) might also control the G(2) checkpoint. Furthermore, PC3(TIS21/BTG2) interacts with carbon catabolite repressor protein-associated factor 1 (CAF-1), a molecule that associates to the yeast transcriptional complex CCR4 and might influence cell cycle, with the transcription factor Hoxb9, and with the protein-arginine methyltransferase 1, that might control transcription through histone methylation. Current evidence suggests a physiological role of PC3(TIS21/BTG2) in the control of cell cycle arrest following DNA damage and other types of cellular stress, or before differentiation of the neuron and other cell types. The molecular function of PC3(TIS21/BTG2) is still unknown, but its ability to modulate cyclin D1 transcription, or to synergize with the transcription factor Hoxb9, suggests that it behaves as a transcriptional co-regulator. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11267995     DOI: 10.1002/jcp.1062

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  82 in total

1.  xBtg-x regulates Wnt/beta-Catenin signaling during early Xenopus development.

Authors:  Oliver Wessely; James I Kim; Uyen Tran; Luis Fuentealba; E M De Robertis
Journal:  Dev Biol       Date:  2005-07-01       Impact factor: 3.582

Review 2.  Global analysis of gene expression in mammalian kidney.

Authors:  Olga Soutourina; Lydie Cheval; Alain Doucet
Journal:  Pflugers Arch       Date:  2004-12-21       Impact factor: 3.657

Review 3.  Microarray-based analysis of ventilator-induced lung injury.

Authors:  Mark M Wurfel
Journal:  Proc Am Thorac Soc       Date:  2007-01

4.  Transcriptome sequencing during mouse brain development identifies long non-coding RNAs functionally involved in neurogenic commitment.

Authors:  Julieta Aprea; Silvia Prenninger; Martina Dori; Tanay Ghosh; Laura Sebastian Monasor; Elke Wessendorf; Sara Zocher; Simone Massalini; Dimitra Alexopoulou; Mathias Lesche; Andreas Dahl; Matthias Groszer; Michael Hiller; Federico Calegari
Journal:  EMBO J       Date:  2013-11-15       Impact factor: 11.598

5.  Biological role of the two overlapping poly(A)-binding protein interacting motifs 2 (PAM2) of eukaryotic releasing factor eRF3 in mRNA decay.

Authors:  Masanori Osawa; Nao Hosoda; Tamiji Nakanishi; Naoyuki Uchida; Tomomi Kimura; Shunsuke Imai; Asako Machiyama; Toshiaki Katada; Shin-ichi Hoshino; Ichio Shimada
Journal:  RNA       Date:  2012-09-27       Impact factor: 4.942

6.  Impaired terminal differentiation of hippocampal granule neurons and defective contextual memory in PC3/Tis21 knockout mice.

Authors:  Stefano Farioli-Vecchioli; Daniele Saraulli; Marco Costanzi; Luca Leonardi; Irene Cinà; Laura Micheli; Michele Nutini; Patrizia Longone; S Paul Oh; Vincenzo Cestari; Felice Tirone
Journal:  PLoS One       Date:  2009-12-17       Impact factor: 3.240

7.  Prosurvival long noncoding RNA PINCR regulates a subset of p53 targets in human colorectal cancer cells by binding to Matrin 3.

Authors:  Ritu Chaudhary; Berkley Gryder; Wendy S Woods; Murugan Subramanian; Matthew F Jones; Xiao Ling Li; Lisa M Jenkins; Svetlana A Shabalina; Min Mo; Mary Dasso; Yuan Yang; Lalage M Wakefield; Yuelin Zhu; Susan M Frier; Branden S Moriarity; Kannanganattu V Prasanth; Pablo Perez-Pinera; Ashish Lal
Journal:  Elife       Date:  2017-06-05       Impact factor: 8.140

8.  BTG2 inhibits the proliferation, invasion, and apoptosis of MDA-MB-231 triple-negative breast cancer cells.

Authors:  Yan-jun Zhang; Lichun Wei; Mei Liu; Jie Li; Yi-qiong Zheng; Ying Gao; Xi-ru Li
Journal:  Tumour Biol       Date:  2013-02-19

9.  Into the unknown: expression profiling without genome sequence information in CHO by next generation sequencing.

Authors:  Fabian Birzele; Jochen Schaub; Werner Rust; Christoph Clemens; Patrick Baum; Hitto Kaufmann; Andreas Weith; Torsten W Schulz; Tobias Hildebrandt
Journal:  Nucleic Acids Res       Date:  2010-03-01       Impact factor: 16.971

10.  BTG interacts with retinoblastoma to control cell fate in Dictyostelium.

Authors:  Daniele Conte; Harry K MacWilliams; Adriano Ceccarelli
Journal:  PLoS One       Date:  2010-03-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.